Table 2. Characteristics related to previous malignancies in patients who underwent pelvic RT history (n=22).
| Characteristic | Value | |
|---|---|---|
| Months between RT and UCS diagnosis (mo) | 123.6 (46.3–293.5) | |
| Type of malignancy | ||
| Uterine cervix | 15 (68.2) | |
| Rectum | 7 (31.8) | |
| Stage of malignancy | ||
| I | 3 (13.6) | |
| II | 8 (36.4) | |
| III | 7 (31.8) | |
| Unknown | 4 (18.2) | |
| Surgical procedure for malignancy | ||
| No | 12 (54.5) | |
| Yes | 10 (45.5) | |
| Treatment | ||
| External RT | 6 (27.3) | |
| External RT followed by brachytherapy | 13 (59.1) | |
| Unknown | 3 (13.6) | |
| RT field | ||
| Pelvis | 16 (72.8) | |
| Semi-extended | 1 (4.5) | |
| Unknown | 5 (22.7) | |
| RT dose (Gy) | 75 (34–93) | |
| CCRT | ||
| No | 13 (59.1) | |
| Yes | 6 (27.3) | |
| Unknown | 3 (13.6) | |
Values are presented as median (range) or number (%).
CCRT, concurrent chemoradiotherapy; RT, radiotherapy; UCS, uterine carcinosarcoma.